Home › Funds › Invesco Ltd › ADPT
Invesco Ltd position in ADPT
ADAPTIVE BIOTECHNOLOGIES COR · Health Care
Latest position (Q2 2026)3.09M sh
Reported value held$66.37M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.51M | $51.41M | New |
| Q4 2021 | 1.55M | $43.47M | Add |
| Q1 2022 | 145.80K | $2.02M | Reduce |
| Q2 2022 | 94.50K | $764.00K | Reduce |
| Q3 2022 | 91.72K | $653.00K | Reduce |
| Q4 2022 | 94.09K | $718.89K | Add |
| Q1 2023 | 106.41K | $939.61K | Add |
| Q2 2023 | 110.19K | $739.35K | Add |
| Q3 2023 | 107.33K | $584.93K | Reduce |
| Q4 2023 | 108.54K | $531.85K | Add |
| Q1 2024 | 174.56K | $560.33K | Add |
| Q2 2024 | 171.86K | $622.13K | Reduce |
| Q3 2024 | 168.61K | $863.26K | Reduce |
| Q4 2024 | 173.59K | $1.04M | Add |
| Q1 2025 | 552.53K | $4.11M | Add |
| Q2 2025 | 908.41K | $10.58M | Add |
| Q3 2025 | 891.06K | $13.33M | Reduce |
| Q4 2025 | 3.11M | $50.47M | Add |
| Q1 2026 | 4.45M | $61.77M | Add |
| Q2 2026 | 3.09M | $66.37M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ADPT
- Viking Global Investors 29.99M sh · $643.37M · Q2 2026
- BlackRock Inc 15.14M sh · $324.73M · Q2 2026
- Vanguard Group 11.28M sh · $183.22M · Q4 2025
- Wellington Management Group 5.91M sh · $126.80M · Q2 2026
- D. E. Shaw & Co 4.63M sh · $99.22M · Q2 2026
- Geode Capital Management 3.64M sh · $78.13M · Q2 2026
- UBS Group AG 3.13M sh · $67.15M · Q2 2026
- Goldman Sachs Group 2.98M sh · $64.01M · Q2 2026
- Arrowstreet Capital 2.52M sh · $54.15M · Q2 2026
- ARK Invest 2.09M sh · $44.84M · Q2 2026
- Bank of America Corp 1.73M sh · $37.11M · Q2 2026